arrow
V

Vivek Subbiah

Sarah Cannon Research Institute
H指数:78
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer
2026-07-060
OA
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients

Ia/b期多中心研究:BPM31510IV单药治疗和联合化疗在实体瘤患者中靶向线粒体代谢/瓦伯格效应的应用

2025-12-010
OA
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors

首次人体研究:一种钍-227标记的间皮素靶向抗体-螯合剂偶联物(MSLN-TTC)在恶性间皮瘤及其他实体瘤患者中的应用

2025-11-200
OAAI
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer

分子肿瘤委员会:国际肺癌研究协会的共识声明

2025-07-070
PRE
Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus

晚期非小细胞肺癌的精准医学管理建议:专家共识

2025-06-270
PRE
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis

循环肿瘤DNA清除作为接受新辅助免疫检查点抑制剂治疗的实体瘤患者病理完全缓解的预测生物标志物:一项系统评价和荟萃分析

2025-04-030
PRE
Precision Oncology: A Global Perspective on Implementation and Policy Development
2025-01-010
OA